BWL
NBIX icon

Bogart Wealth LLC’s Neurocrine Biosciences NBIX Stock Holding History

Bogart Wealth LLC’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$659 Buy
5
+1
+25% +$133 ﹤0.01% 1526
2025
Q4 		$567 Sell
4
-4
-50% -$579 ﹤0.01% 1429
2025
Q3 		$1.12K Buy
8
+4
+100% +$542 ﹤0.01% 1258
2025
Q2 		$503 Buy
+4
New +$459 ﹤0.01% 1352

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bogart Wealth LLC's NBIX Position: Q1 2026 in Review

Bogart Wealth LLC increased its Neurocrine Biosciences (NBIX) stake by 25% in Q1 2026, buying an estimated $133 and bringing the position to 5 shares worth $659. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Bogart Wealth LLC first reported a position in NBIX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.12K in Q3 2025. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Bogart Wealth LLC held 5 shares of Neurocrine Biosciences worth $659 as of Q1 2026.
  • Bogart Wealth LLC bought 1 Neurocrine Biosciences share in Q1 2026, an estimated $133.
  • Neurocrine Biosciences made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1526 holding.
  • Bogart Wealth LLC first reported a position in Neurocrine Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Bogart Wealth LLC's Neurocrine Biosciences position peaked at $1.12K in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.